Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells

Molecular and Cellular Endocrinology

Volumn 251, Issue 1-2, 2006, Pages 42-48

  Hanai, Yoshiteru ^a,b   Tokuda, Haruhiko ^a,b   Ishisaki, Akira ^c   Matsushima Nishiwaki, Rie ^b   Nakamura, Norimi ^a   Yoshida, Minoru ^b   Takai, Shinji ^b   Ohta, Toshiki ^a   Kozawa, Osamu ^b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Alkaline phosphatase; IGF I; Osteoblast; p44 p42 MAP kinase

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALKALINE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; SOMATOMEDIN; STRESS ACTIVATED PROTEIN KINASE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; INSULIN-LIKE GROWTH FACTOR I; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION;

EID: 33646560640     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.02.014     Document Type: Article

References (30)

1. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J. Biol. Chem. 270 (1995) 27489-27494
2. Arcaro A., and Wymann M.P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296 (1993) 297-301
3. Aubin J.E., and Liu F. The osteoblast lineage. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (1996), Academic Press, San Diego 51-68
4. Conover C.A. In vitro studies of insulin-like growth factor I and bone. Growth Horm. IGF Res. 10 (2000) S107-S110
5. Conover C.A., and Rosen C. The role of insulin-like growth factors and binding proteins in bone cell biology. In: Bilwzikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology. second ed. (2002), Academic Press, San Diego 801-815
6. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
7. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 18623-18632
8. Fedde K.N., Blair L., Silverstein J., Coburn S.P., Ryan L.M., Weinstein R.S., Waymire K., Narisawa S., Millan J.L., MacGregor G.R., and Whyte M.P. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J. Bone Miner. Res. 14 (1999) 2015-2026
9. Ishisaki A., Tsunobuchi H., Nakajima K., and Imamura T. Possible involvement of protein kinase C activation in differentiation of human umbilical vein endothelium-derived cell into smooth muscle-like cell. Biol. Cell. 96 (2004) 499-508
10. Kato K., Ito H., Hasegawa K., Inaguma Y., Kozawa O., and Asano T. Modulation of the stress-induced synthesis of hsp27 and αB-crystallin by cyclic AMP in C6 glioma cells. J. Neurochem. 66 (1996) 946-950
11. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
12. Kozawa O., Takatsuki K., Kotake K., Yoneda M., Oiso Y., and Saito H. Possible involvement of protein kinase C in proliferation and differentiation of osteoblast-like cells. FEBS Lett. 243 (1989) 183-185
13. Kozawa O., Tokuda H., Miwa M., Kotoyori J., and Oiso Y. Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E2 in osteoblast-like cells. Exp. Cell Res. 198 (1992) 130-134
14. 45Ca-accumulation in cultures of osteoblast-like cells: possible involvement of insulin-like growth factor-I. Bone Miner. 19 (1992) 235-243
15. Kummer J.L., Rao P.K., and Heidenreich K.A. Apoptosis induced by withdrawal of trophic factor is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 272 (1997) 20490-20494
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
17. Lowry O.H., Roberts N., Wu M.L., Hixon W.S., and Crawford E.J. The quantitative histochemistry of brain. II. Enzyme measurements. J. Biol. Chem. 207 (1954) 19-37
18. Nakashima A., Katagiri T., and Tamura M. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J. Biol. Chem. 280 (2005) 37660-37668
19. Nijweide P.J., Burger E.H., and Feyen J.H.M. Cells of bone: proliferation, differentiation, and humoral regulation. Physiol. Rev. 66 (1986) 855-886
20. Noda T., Tokuda H., Yoshida M., Yasuda E., Hanai Y., Takai S., and Kozawa O. Possible involvement of phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts. Horm. Metab. Res. 37 (2005) 270-274
21. Olney R.C. Regulation of bone mass by growth hormone. Med. Pediatr. Oncol. 41 (2003) 228-234
22. Pei Y., Meng X.W., Zhou X.Y., Xing X.P., and Xia W.B. Expression of core binding factor α1 up-regulated by IGF-GM-CSF, and EGF through MAPK pathway in MC3T3-E1 and C2C12 cells. Acta Pharmacol. Sci. 24 (2003) 975-984
23. Raingeaud J., Gupta S., Rogers J.S., Dickens M., Han J., Ulevitch R.J., and David R.J. Pro-inflammatory cytokines and environmental stress cause p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270 (1995) 7420-7426
24. Robinson R.J., Doty S.B., and Cooper R.R. Electron microscopy of mammalian bone. In: Zipkin I. (Ed). Biological Mineralization (1973), Academic Press Inc., New York 257-296
25. Schmid C., Steiner T., and Froesch E.R. Insulin-like growth factor I supports differentiation of cultured osteoblast-like cells. FEBS Lett. 173 (1984) 48-52
26. Seibel M.J. Molecular markers of bone turnover: biochemical, technical and analytical aspects. Osteoporos. Int. 6 (2000) S18-S29
27. Sudo H., Kodama H., Amagai Y., Yamamoto S., and Kasai S. In vivo differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96 (1983) 191-198
28. Trippel S.B. Potential role of insulin like growth factors in fracture healing. Clin. Orthop. 355 (1998) S301-S313
29. Vlahos C.J., Matter W.F., Hui K.Y., and Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269 (1994) 5241-5248
30. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79 (1999) 143-180